Codexis, Inc. (CDXS): Price and Financial Metrics
Codexis, Inc. (CDXS)
Today's Latest Price: $14.41 USD
Updated Oct 23 4:00pm
Add CDXS to WatchlistSign Up
POWR Components:
Trade Grade Buy & Hold Grade Peer Grade Industry Rank
Industry Rank:
See all "A" rated Strong Buy stocks
CDXS Stock Summary
- With a one year PEG ratio of 6,772.37, Codexis Inc is expected to have a higher PEG ratio (a measure of how expensive a stock is relative to its expected earnings growth) than 99.6% of US stocks.
- CDXS's price/sales ratio is 11.73; that's higher than the P/S ratio of 88.07% of US stocks.
- CDXS's equity multiplier -- a measure of assets relative to shareholders'equity -- is greater than that of merely 22.36% of US stocks.
- If you're looking for stocks that are quantitatively similar to Codexis Inc, a group of peers worth examining would be HRTX, AMOT, AMSWA, ICCC, and QUIK.
- CDXS's SEC filings can be seen here. And to visit Codexis Inc's official web site, go to www.codexis.com.
CDXS Stock Price Chart Interactive Chart >
CDXS Price/Volume Stats
| Current price | $14.41 | 52-week high | $18.87 |
| Prev. close | $14.21 | 52-week low | $8.43 |
| Day low | $14.18 | Volume | 273,700 |
| Day high | $14.47 | Avg. volume | 376,162 |
| 50-day MA | $12.94 | Dividend yield | N/A |
| 200-day MA | $12.53 | Market Cap | 852.02M |
Codexis, Inc. (CDXS) Company Bio
Codexis, Inc. develops biocatalysts for the pharmaceutical and fine chemicals markets in the United States and internationally. The company offers Codex biocatalyst panels and kits to pharmaceutical companies that are engaged in drug development and the marketing of approved drugs to allow them to screen and identify possible enzymatic manufacturing processes for their drug candidates and their marketed products. The company was founded in 2002 and is based in Redwood City, California.
Loading social stream, please wait...